TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

NCT02429687 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Germ Cell Cancer
Ovarian Neoplasms
Ovarian Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Bleomycin
DRUG: Etoposide
DRUG: Cisplatin

Sponsor

Beihua Kong

Collaborators

[object Object]
[object Object]
[object Object]